The Board has decided to remand the case due to insufficient evidence regarding the cause of the Veteran's interstitial pulmonary fibrosis. A new VA examination is required to clarify this issue.
The deciding factor: The examiner must provide an opinion on whether it is at least as likely as not that the Veteran's service-connected condition was caused by exposure to chemicals at Camp Lejeune and/or herbicide agents, including aggravation of a pre-existing condition.
- Claimed conditions
- Interstitial pulmonary fibrosis, Interstitial pneumonia
- How they argued it
- Not specified
- Exposure basis
- Camp Lejeune water
- Rating
- Not verified here — check the original decision
- Decision date
- September 7, 2023
- Citation
- 23049348
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23049348.
What this means for you
A remand sends an issue back for more development, often a new examination or missing records. It does not award the benefit or decide the final outcome. The original decision explains the additional work ordered.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Board has granted service connection for interstitial pulmonary fibrosis as secondary to in-service exposure to toxins from explosives and mortars, and for bladder cancer as secondary to in-service exposure to forever chemicals.
- Whole decision: Granted
The Board granted an effective date of February 12, 2019, for the grant of service connection for interstitial pulmonary fibrosis based on a liberalizing law.
- Whole decision: Partly granted
The Board granted a 30 percent rating for benign paroxysmal positional vertigo (BPPV) prior to June 12, 2024, and denied all other claims including service connection for various respiratory conditions.
- Whole decision: Granted
The Board granted an initial rating of 60 percent for interstitial pulmonary fibrosis, effective August 10, 2022.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.